4-(CYCLOPROPYLMETHOXY)-2-FLUOROBENZOIC ACID, 95.0%, 100mg

2-(1H-Benzo[d]imidazol-2-yl)-4,5-dihydrooxazole, 97%, 1g

3-Nitroquinolin-4-amine, 95.0%, 5g

(+)-10-Camphorsulfonic Acid>98.0%(T)25g

(3aR,3a'R,8aS,8a'S)-2,2'-(Cyclopropane-1,1-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 98.0%, 1g

(S)-1-Boc-2-Methyl-[1,4]diazepane, 95.0%, 250mg

(R)-2-Benzylpyrrolidine-2-carboxylic acid hydrochloride, 98%, 100mg

4-Chloro-7-(trifluoromethyl)quinazoline, 95.0%, 10g

(S)-3-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

(1R,5R)-3-methyl-3,6-diazabicyclo[3.2.0]heptane; bis(trifluoroacetic acid), 95.0%, 250mg

2-(4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)thiazol-2-yl)acetonitrile, 98%, 250mg

1-(2-Bromo-4-(trifluoromethyl)phenyl)ethanone, 95.0%, 100mg

(R)-2-((tert-Butoxycarbonyl)amino)-3,3-diphenylpropanoic acid, 95.0%, 25g